Interacciones neuroinmunes: cómo las lecciones del pasado pueden informar el presente y el futuro de la atención de

Adil Harroud1,2,3, Jack P Antel1,2

  • 1The Neuro (Montreal Neurological Institute-Hospital), Montréal, QC, Canada.

Multiple sclerosis (Houndmills, Basingstoke, England)
|September 1, 2025
PubMed
Resumen

Las interacciones neuroinmunes son cruciales en la patogénesis de la esclerosis múltiple (EM). Esta revisión explora cómo el sistema inmunológico y el sistema nervioso central (SNC) se influyen mutuamente, lo que afecta la progresión y el tratamiento de la EM.

Videos de Conceptos Relacionados

Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
312
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.4K
The Blood-brain Barrier00:49

The Blood-brain Barrier

Overview
48.6K
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.9K